Skip to main content

Advertisement

SpringerLink
Log in

Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study aims to compare the mean platelet volume (MPV) levels in children and adults diagnosed with familial Mediterranean fever (FMF) during attack-free periods in order to find out whether it reflects the emergence of microalbuminuria/proteinuria and the development of amyloidosis or not. The study consisted of 63 pediatric patients (group 1), 50 adult patients (group 2), 50 healthy children (group 3), and 43 healthy adults (group 4). Demographic data, age at diagnosis, duration of the disease and colchicine treatment, and FMF gene mutations were recorded, and erythrocyte sedimentation rate, C-reactive protein, fibrinogen, hemoglobin, white blood cell count, platelet count, MPV, blood urea nitrogen, creatine, albumin, and urine microalbumin and protein levels were evaluated. According to the presence of microalbuminuria/proteinuria, patient groups were subgrouped into two by themselves as pediatric and adult groups with and without proteinuria. The most frequent mutation was M694V. MPV was significantly higher in FMF patients than those in the healthy control groups. Microalbuminuria/proteinuria were detected in 18 (28.57 %) of 63 pediatric patients and 26 (52 %) of 50 adult patients. Amyloidosis has been identified in 3 (16.6 %) of 18 pediatric patients and 18 (69.23 %) of 26 adult patients with proteinuria. Subgroup comparisons revealed that MPV levels were significantly higher in patients with proteinuria than patients without proteinuria in both pediatric and adult groups. Moreover, MPV levels were also significantly higher in adult patients with or without proteinuria than in pediatric patients with or without proteinuria. There were significant differences in terms of serum albumin levels between the groups with and without proteinuria as expected. The increase in MPV over the years of the disease, especially in groups with proteinuria, may be an important predictor of continuing increase of subclinical inflammation, the emergence of the microalbuminuria/proteinuria, and the developing of amyloidosis, but further studies are needed in order to support this proposal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43(2):227–253

    Article  CAS  PubMed  Google Scholar 

  2. Rogers DB, Shohat M, Petersen GM, Bickal J, Congleton J, Schwabe AD, Rotter JI (1989) Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency. Am J Med Genet 34(2):168–172

    Article  CAS  PubMed  Google Scholar 

  3. Schwabe AD, Peters RS (1974) Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine (Baltimore) 53(6):453–462

    Article  CAS  Google Scholar 

  4. Tauber T, Zimand S, Kotzer E. (1995) Recurrent pericarditis in familial Mediterranean fever. Harefuah 128(10):611–2, 672.

    Google Scholar 

  5. Mimouni A, Magal N, Stoffman N, Shohat T, Minasian A, Krasnov M, Halpern GJ, Rotter JI, Fischel-Ghodsian N, Danon YL, Shohat M (2000) Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 105(5):E70

    Article  CAS  PubMed  Google Scholar 

  6. Bunker D, Gorevic P (2012) AA amyloidosis: Mount Sinai experience, 1997–2012. Mt Sinai J Med 79(6):749–756

    Article  PubMed  Google Scholar 

  7. Obici L, Merlini G (2012) AA amyloidosis: basic knowledge, unmet needs and future treatments. Swiss Med Wkly 142:w13580

    PubMed  Google Scholar 

  8. Pras M, Bronshpigel N, Zemer D, Gafni J (1982) Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med J 150(1):22–26

    CAS  PubMed  Google Scholar 

  9. Arıca S, Ozer C, Arıca V, Karakuş A, Celik T, Güneşaçar R (2011) Evaluation of the mean platelet volume in children with familial Mediterranean fever. Rheumatol Int 32(11):3559–3563. doi:10.1007/s00296-011-2251-x

    Article  PubMed  Google Scholar 

  10. van der Hilst JC (2011) Recent insights into the pathogenesis of type AA amyloidosis. Scientific World Journal 7(11):641–650

    Article  Google Scholar 

  11. Sato H, Kuroda T, Tanabe N, Ajiro J, Wada Y, Murakami S, Sakatsume M, Nakano M, Gejyo F (2010) Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis. Scand J Rheumatol 39(1):33–37

    Article  CAS  PubMed  Google Scholar 

  12. Tishko AN, Lapin SV, Vavilova TV, Totolian AA (2011) Early diagnostics of kidney damage in longstanding rheumatoid arthritis and amyloidosis. Amyloid 18(1):217–218

    Article  PubMed  Google Scholar 

  13. Turkcapar N, Tuncali T, Kutlay S, Burhan BY, Kinikli G, Erturk S, Duman M (2007) The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. Rheumatol Int 27(6):545–551

    Article  CAS  PubMed  Google Scholar 

  14. Ergüven M, Emeksiz C, Deveci M, Ozlü SG (2008) Relation between microalbuminuria and gene mutations in familial Mediterranean fever. Turk J Pediatr 50(4):326–330

    PubMed  Google Scholar 

  15. Albayrak F, Selcuk NY, Odabas AR, Cetinkaya R, Pirim I (2010) Genotype–phenotype correlation in patients with familial Mediterranean fever in East Anatolia (Turkey). Genet Test Mol Biomarkers 14(3):325–328

    Article  PubMed  Google Scholar 

  16. Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61(1):79–81

    Article  CAS  PubMed  Google Scholar 

  17. Ulasli SS, Ozyurek BA, Yilmaz EB, Ulubay G (2012) Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Pol Arch Med Wewn 122(6):284–290

    CAS  PubMed  Google Scholar 

  18. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA (2001) Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 96(3):776–781

    Article  CAS  PubMed  Google Scholar 

  19. Milovanovic M, Nilsson E, Järemo P (2004) Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 343(1–2):237–240

    Article  CAS  PubMed  Google Scholar 

  20. Yazici S, Yazici M, Erer B, Erer B, Calik Y, Ozhan H, Ataoglu S (2010) The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 21(2):122–125

    Article  CAS  PubMed  Google Scholar 

  21. Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M (2008) Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75(3):291–294

    Article  PubMed  Google Scholar 

  22. Coban E, Adanir H (2008) Platelet activation in patients with familial Mediterranean fever. Platelets 19(6):405–408

    Article  CAS  PubMed  Google Scholar 

  23. Makay B, Türkyilmaz Z, Unsal E (2009) Mean platelet volume in children with familial Mediterranean fever. Clin Rheumatol 28(8):975–978

    Article  PubMed  Google Scholar 

  24. Sahin S, Senel S, Ataseven H, Yalcin I (2012) Does mean platelet volume influence the attack or attack-free period in the patients with familial Mediterranean fever? Platelets 122(6):284–90

    Google Scholar 

  25. Kabata J, Raszeja-Specht A, Steffek I, Angielski S (1995) Reference values for peripheral blood morphology in countryside population of northern Poland. Pol Tyg Lek 50(36–39):62–65

    CAS  PubMed  Google Scholar 

  26. Shiga S, Koyanagi I, Ohsaga J, Ichiyama S, Kannagi R (1999) Clinical reference values for laboratory hematology tests calculated using the iterative truncation method with correction: part 2, reference values for white blood cell (WBC) count, WBC differential including segmented neutrophil, band neutrophil, lymphocyte, monocyte, eosinophil, basophil, platelet count and mean platelet volume. Rinsho Byori 47(3):281–288

    CAS  PubMed  Google Scholar 

  27. Daniels M, Shohat T, Brenner-Ullman A, Shohat M (1995) Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am J Med Genet 55(3):311–314

    Article  CAS  PubMed  Google Scholar 

  28. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17(1):47–58

    Article  CAS  PubMed  Google Scholar 

  29. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD (2010) Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy. Rheumatol Int 30(8):1125–1129

    Article  CAS  PubMed  Google Scholar 

  30. Zubcevic N, Mesihovic R, Zubcevic S (2010) Usefulness of laboratory data in estimation of Crohn’s disease activity. Med Arh 64(1):33–36

    PubMed  Google Scholar 

  31. Yalçinkaya F, Cakar N, Acar B, Tutar E, Güriz H, Elhan AH, Oztürk S, Kansu A, Ince E, Atalay S, Girgin N, Doğru U, Aysev D, Ekim M (2007) The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study. Rheumatol Int 27(6):517–522

    Article  PubMed  Google Scholar 

  32. Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F, Bassoy Y, Yilmaz E (2003) Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 21(4):509–514

    CAS  PubMed  Google Scholar 

  33. Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, Bagci S (2004) Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol 138(3):526–533

    Article  CAS  PubMed  Google Scholar 

  34. Tunca M, Kirkali G, Soytürk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response and evolution of familial Mediterranean fever. Lancet 353:1415

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Pediatric Nephrology, Baskent University Faculty of Medicine, Konya, Turkey

    Hale Sakallı

  2. Department of Nephrology, Baskent University Faculty of Medicine, Konya, Turkey

    Öznur Kal

Authors
  1. Hale Sakallı
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Öznur Kal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hale Sakallı.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakallı, H., Kal, Ö. Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever. Clin Rheumatol 32, 1185–1190 (2013). https://doi.org/10.1007/s10067-013-2257-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-013-2257-8

Keywords

Search

Navigation